Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.
Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Gomez Valderas E, Das S, Lee CJ, Glass LC, Senyucel C, Dunn JP; SURMOUNT-5 Trial Investigators. Aronne LJ, et al. Among authors: horn db. N Engl J Med. 2025 Jul 3;393(1):26-36. doi: 10.1056/NEJMoa2416394. Epub 2025 May 11. N Engl J Med. 2025. PMID: 40353578 Clinical Trial.
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial.
Ryan DH, Lingvay I, Deanfield J, Kahn SE, Barros E, Burguera B, Colhoun HM, Cercato C, Dicker D, Horn DB, Hovingh GK, Jeppesen OK, Kokkinos A, Lincoff AM, Meyhöfer SM, Oral TK, Plutzky J, van Beek AP, Wilding JPH, Kushner RF. Ryan DH, et al. Among authors: horn db. Nat Med. 2024 Jul;30(7):2049-2057. doi: 10.1038/s41591-024-02996-7. Epub 2024 May 13. Nat Med. 2024. PMID: 38740993 Free PMC article. Clinical Trial.
Assessing the state of obesity care: Quality, access, guidelines, and standards.
Kaplan LM, Apovian CM, Ard JD, Allison DB, Aronne LJ, Batterham RL, Busetto L, Dicker D, Horn DB, Kelly AS, Mechanick JI, Purnell JQ, Ramos-Salas X; Assessing the State of Obesity Care Writing Group. Kaplan LM, et al. Among authors: horn db. Obes Sci Pract. 2024 Jul 17;10(4):e765. doi: 10.1002/osp4.765. eCollection 2024 Aug. Obes Sci Pract. 2024. PMID: 39026558 Free PMC article.
Missing the Target: A Scoping Review of the Use of Percent Weight Loss for Obesity Management.
Sherifali D, Racey M, Fitzpatrick-Lewis D, Greenway M, Sockalingam S, Wada J, Teoh SH, Patton I, Macklin D, van Rossum EFC, Busetto L, Horn DB, Patricia Nece JD, Leguede MEGS, Pearce N, Le Roux C, Ard J, Alberga AS, Kaplan L, Sharma AM, Wharton S. Sherifali D, et al. Among authors: horn db. Obes Rev. 2025 Jun 3:e13960. doi: 10.1111/obr.13960. Online ahead of print. Obes Rev. 2025. PMID: 40461407 Review.
Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.
Kahn SE, Deanfield JE, Jeppesen OK, Emerson SS, Boesgaard TW, Colhoun HM, Kushner RF, Lingvay I, Burguera B, Gajos G, Horn DB, Hramiak IM, Jastreboff AM, Kokkinos A, Maeng M, Matos ALSA, Tinahones FJ, Lincoff AM, Ryan DH; SELECT Trial Investigators. Kahn SE, et al. Among authors: horn db. Diabetes Care. 2024 Aug 1;47(8):1350-1359. doi: 10.2337/dc24-0491. Diabetes Care. 2024. PMID: 38907683 Free PMC article. Clinical Trial.
Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society.
Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, Bonnet J, Butsch WS, Christensen S, Gianos E, Gulati M, Gupta A, Horn D, Kane RM, Saluja J, Sannidhi D, Fatima Cody S, Callahan EA. Mozaffarian D, et al. Am J Lifestyle Med. 2025 May 30:15598276251344827. doi: 10.1177/15598276251344827. Online ahead of print. Am J Lifestyle Med. 2025. PMID: 40452753 Free PMC article.
100 results